<!doctype html><html lang=en class=no-js> <head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><link rel=icon href=../../assets/images/favicon.png><meta name=generator content="mkdocs-1.3.0, mkdocs-material-8.2.13"><title>Atrial Fibrillation - MDnotes</title><link rel=stylesheet href=../../assets/stylesheets/main.e411adfe.min.css><link rel=stylesheet href=../../assets/stylesheets/palette.cc9b2e1e.min.css><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback"><style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style><script>__md_scope=new URL("../..",location),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script></head> <body dir=ltr data-md-color-scheme=default data-md-color-primary=indigo data-md-color-accent=indigo> <script>var palette=__md_get("__palette");if(palette&&"object"==typeof palette.color)for(var key of Object.keys(palette.color))document.body.setAttribute("data-md-color-"+key,palette.color[key])</script> <input class=md-toggle data-md-toggle=drawer type=checkbox id=__drawer autocomplete=off> <input class=md-toggle data-md-toggle=search type=checkbox id=__search autocomplete=off> <label class=md-overlay for=__drawer></label> <div data-md-component=skip> <a href=#atrial-fibrillation class=md-skip> Skip to content </a> </div> <div data-md-component=announce> </div> <header class=md-header data-md-component=header> <nav class="md-header__inner md-grid" aria-label=Header> <a href=../.. title=MDnotes class="md-header__button md-logo" aria-label=MDnotes data-md-component=logo> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="m4.22 11.29 7.07-7.07a6.011 6.011 0 0 1 8.49 0c2.34 2.34 2.34 6.14 0 8.49l-7.07 7.07c-2.35 2.34-6.15 2.34-8.49 0a6.011 6.011 0 0 1 0-8.49m1.42 1.42a3.976 3.976 0 0 0-1.04 3.86l5.99-5.98 4.24 4.24 3.53-3.54a3.978 3.978 0 0 0 0-5.65 3.978 3.978 0 0 0-5.65 0l-7.07 7.07Z"/></svg> </a> <label class="md-header__button md-icon" for=__drawer> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg> </label> <div class=md-header__title data-md-component=header-title> <div class=md-header__ellipsis> <div class=md-header__topic> <span class=md-ellipsis> MDnotes </span> </div> <div class=md-header__topic data-md-component=header-topic> <span class=md-ellipsis> Atrial Fibrillation </span> </div> </div> </div> <form class=md-header__option data-md-component=palette> <input class=md-option data-md-color-media="(prefers-color-scheme: light)" data-md-color-scheme=default data-md-color-primary=indigo data-md-color-accent=indigo aria-label="Switch to dark mode" type=radio name=__palette id=__palette_1> <label class="md-header__button md-icon" title="Switch to dark mode" for=__palette_2 hidden> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg> </label> <input class=md-option data-md-color-media="(prefers-color-scheme: dark)" data-md-color-scheme=slate data-md-color-primary=blue data-md-color-accent=blue aria-label="Switch to light mode" type=radio name=__palette id=__palette_2> <label class="md-header__button md-icon" title="Switch to light mode" for=__palette_1 hidden> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg> </label> </form> <label class="md-header__button md-icon" for=__search> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg> </label> <div class=md-search data-md-component=search role=dialog> <label class=md-search__overlay for=__search></label> <div class=md-search__inner role=search> <form class=md-search__form name=search> <input type=text class=md-search__input name=query aria-label=Search placeholder=Search autocapitalize=off autocorrect=off autocomplete=off spellcheck=false data-md-component=search-query required> <label class="md-search__icon md-icon" for=__search> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg> </label> <nav class=md-search__options aria-label=Search> <button type=reset class="md-search__icon md-icon" aria-label=Clear tabindex=-1> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg> </button> </nav> </form> <div class=md-search__output> <div class=md-search__scrollwrap data-md-scrollfix> <div class=md-search-result data-md-component=search-result> <div class=md-search-result__meta> Initializing search </div> <ol class=md-search-result__list></ol> </div> </div> </div> </div> </div> </nav> </header> <div class=md-container data-md-component=container> <main class=md-main data-md-component=main> <div class="md-main__inner md-grid"> <div class="md-sidebar md-sidebar--primary" data-md-component=sidebar data-md-type=navigation> <div class=md-sidebar__scrollwrap> <div class=md-sidebar__inner> <nav class="md-nav md-nav--primary" aria-label=Navigation data-md-level=0> <label class=md-nav__title for=__drawer> <a href=../.. title=MDnotes class="md-nav__button md-logo" aria-label=MDnotes data-md-component=logo> <svg xmlns=http://www.w3.org/2000/svg viewbox="0 0 24 24"><path d="m4.22 11.29 7.07-7.07a6.011 6.011 0 0 1 8.49 0c2.34 2.34 2.34 6.14 0 8.49l-7.07 7.07c-2.35 2.34-6.15 2.34-8.49 0a6.011 6.011 0 0 1 0-8.49m1.42 1.42a3.976 3.976 0 0 0-1.04 3.86l5.99-5.98 4.24 4.24 3.53-3.54a3.978 3.978 0 0 0 0-5.65 3.978 3.978 0 0 0-5.65 0l-7.07 7.07Z"/></svg> </a> MDnotes </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../.. class=md-nav__link> Home </a> </li> <li class=md-nav__item> <a href=../../Key%20Studies/ class=md-nav__link> Key Studies </a> </li> <li class="md-nav__item md-nav__item--active md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_3 type=checkbox id=__nav_3 checked> <label class=md-nav__link for=__nav_3> Cardiology <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Cardiology data-md-level=1> <label class=md-nav__title for=__nav_3> <span class="md-nav__icon md-icon"></span> Cardiology </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../ARB%20Comparisons/ class=md-nav__link> ARB Comparisons </a> </li> <li class="md-nav__item md-nav__item--active"> <input class="md-nav__toggle md-toggle" data-md-toggle=toc type=checkbox id=__toc> <label class="md-nav__link md-nav__link--active" for=__toc> Atrial Fibrillation <span class="md-nav__icon md-icon"></span> </label> <a href=./ class="md-nav__link md-nav__link--active"> Atrial Fibrillation </a> <nav class="md-nav md-nav--secondary" aria-label="Table of contents"> <label class=md-nav__title for=__toc> <span class="md-nav__icon md-icon"></span> Table of contents </label> <ul class=md-nav__list data-md-component=toc data-md-scrollfix> <li class=md-nav__item> <a href=#definitions-background class=md-nav__link> Definitions &amp; Background </a> </li> <li class=md-nav__item> <a href=#pathophysiology class=md-nav__link> Pathophysiology </a> </li> <li class=md-nav__item> <a href=#consequences class=md-nav__link> Consequences </a> </li> <li class=md-nav__item> <a href=#chronic-management-of-atrial-fibrillation class=md-nav__link> Chronic Management of Atrial Fibrillation </a> <nav class=md-nav aria-label="Chronic Management of Atrial Fibrillation"> <ul class=md-nav__list> <li class=md-nav__item> <a href=#rate-versus-rhythm-control class=md-nav__link> Rate versus Rhythm Control </a> </li> <li class=md-nav__item> <a href=#rate-control class=md-nav__link> Rate Control </a> </li> <li class=md-nav__item> <a href=#rhythm-control class=md-nav__link> Rhythm Control </a> </li> <li class=md-nav__item> <a href=#risk-stratification class=md-nav__link> Risk Stratification </a> <nav class=md-nav aria-label="Risk Stratification"> <ul class=md-nav__list> <li class=md-nav__item> <a href=#risk-of-stroke class=md-nav__link> Risk of Stroke </a> </li> <li class=md-nav__item> <a href=#risk-of-bleeding class=md-nav__link> Risk of Bleeding </a> </li> </ul> </nav> </li> <li class=md-nav__item> <a href=#anticoagulation class=md-nav__link> Anticoagulation </a> </li> </ul> </nav> </li> <li class=md-nav__item> <a href=#resources-references class=md-nav__link> Resources &amp; References </a> </li> </ul> </nav> </li> <li class=md-nav__item> <a href=../Tachycardia/ class=md-nav__link> Tachycardia </a> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_3_4 type=checkbox id=__nav_3_4> <label class=md-nav__link for=__nav_3_4> Acute Coronary Syndromes <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Acute Coronary Syndromes" data-md-level=2> <label class=md-nav__title for=__nav_3_4> <span class="md-nav__icon md-icon"></span> Acute Coronary Syndromes </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../Acute%20Coronary%20Syndromes/STEMI/ class=md-nav__link> STEMI </a> </li> <li class=md-nav__item> <a href=../Acute%20Coronary%20Syndromes/UA%20and%20NSTEMI/ class=md-nav__link> UA and NSTEMI </a> </li> <li class=md-nav__item> <a href=../Acute%20Coronary%20Syndromes/lv-thrombus/ class=md-nav__link> Lv thrombus </a> </li> <li class=md-nav__item> <a href=../Acute%20Coronary%20Syndromes/spontaneous-coronary-artery-dissection-scad/ class=md-nav__link> Spontaneous coronary artery dissection scad </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_3_5 type=checkbox id=__nav_3_5> <label class=md-nav__link for=__nav_3_5> Chronic Coronary Syndromes <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Chronic Coronary Syndromes" data-md-level=2> <label class=md-nav__title for=__nav_3_5> <span class="md-nav__icon md-icon"></span> Chronic Coronary Syndromes </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../Chronic%20Coronary%20Syndromes/compass-2017/ class=md-nav__link> Compass 2017 </a> </li> <li class=md-nav__item> <a href=../Chronic%20Coronary%20Syndromes/coronary-ct-angiography-ccta/ class=md-nav__link> Coronary ct angiography ccta </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_3_6 type=checkbox id=__nav_3_6> <label class=md-nav__link for=__nav_3_6> Heart Failure <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Heart Failure" data-md-level=2> <label class=md-nav__title for=__nav_3_6> <span class="md-nav__icon md-icon"></span> Heart Failure </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../Heart%20Failure/Chronic%20Heart%20Failure/ class=md-nav__link> Chronic Heart Failure </a> </li> <li class=md-nav__item> <a href=../Heart%20Failure/HFrEF%20Drug%20Doses/ class=md-nav__link> HFrEF Drugs </a> </li> </ul> </nav> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_4 type=checkbox id=__nav_4> <label class=md-nav__link for=__nav_4> Critical Care <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Critical Care" data-md-level=1> <label class=md-nav__title for=__nav_4> <span class="md-nav__icon md-icon"></span> Critical Care </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Critical%20Care/ACLS%20101/ class=md-nav__link> ACLS 101 </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Acetaminophen%20Overdose/ class=md-nav__link> Acetaminophen Overdose/Toxicity </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Toxidromes/ class=md-nav__link> Toxicology </a> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_4_4 type=checkbox id=__nav_4_4> <label class=md-nav__link for=__nav_4_4> Oxygenation, Ventilation, ARDS <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Oxygenation, Ventilation, ARDS" data-md-level=2> <label class=md-nav__title for=__nav_4_4> <span class="md-nav__icon md-icon"></span> Oxygenation, Ventilation, ARDS </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Critical%20Care/Oxygenation%2C%20Ventilation%2C%20ARDS/acute-respiratory-distress-syndrome/ class=md-nav__link> Acute respiratory distress syndrome </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Oxygenation%2C%20Ventilation%2C%20ARDS/liberation-from-mechanical-ventilation/ class=md-nav__link> Liberation from mechanical ventilation </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Oxygenation%2C%20Ventilation%2C%20ARDS/modes-of-ventilation-and-ventilator-strategies/ class=md-nav__link> Modes of ventilation and ventilator strategies </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Oxygenation%2C%20Ventilation%2C%20ARDS/neuromuscular-blockade/ class=md-nav__link> Neuromuscular blockade </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Oxygenation%2C%20Ventilation%2C%20ARDS/noninvasive-ventilation/ class=md-nav__link> Noninvasive ventilation </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Oxygenation%2C%20Ventilation%2C%20ARDS/patient-ventilator-dyssynchrony/ class=md-nav__link> Patient ventilator dyssynchrony </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Oxygenation%2C%20Ventilation%2C%20ARDS/proning-in-ards/ class=md-nav__link> Proning in ards </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Oxygenation%2C%20Ventilation%2C%20ARDS/recruitment-maneuvres-in-ards/ class=md-nav__link> Recruitment maneuvres in ards </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_4_5 type=checkbox id=__nav_4_5> <label class=md-nav__link for=__nav_4_5> Sepsis <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Sepsis data-md-level=2> <label class=md-nav__title for=__nav_4_5> <span class="md-nav__icon md-icon"></span> Sepsis </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Critical%20Care/Sepsis/steroids-in-septic-shock/ class=md-nav__link> Steroids in septic shock </a> </li> <li class=md-nav__item> <a href=../../Critical%20Care/Sepsis/vasoactive-medications-in-septic-shock/ class=md-nav__link> Vasoactive medications in septic shock </a> </li> </ul> </nav> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_5 type=checkbox id=__nav_5> <label class=md-nav__link for=__nav_5> Endocrinology <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Endocrinology data-md-level=1> <label class=md-nav__title for=__nav_5> <span class="md-nav__icon md-icon"></span> Endocrinology </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Endocrinology/Diabetes%20Mellitus/ class=md-nav__link> Diabetes Mellitus </a> </li> <li class=md-nav__item> <a href=../../Endocrinology/Dyslipidemia/ class=md-nav__link> Dyslipidemia </a> </li> <li class=md-nav__item> <a href=../../Endocrinology/Hypercalcemia/ class=md-nav__link> Hypercalcemia </a> </li> <li class=md-nav__item> <a href=../../Endocrinology/Insulin%20Neuritis/ class=md-nav__link> Treatment-induced neuropathy of diabetes (TIND) </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_6 type=checkbox id=__nav_6> <label class=md-nav__link for=__nav_6> Gastroenterology <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Gastroenterology data-md-level=1> <label class=md-nav__title for=__nav_6> <span class="md-nav__icon md-icon"></span> Gastroenterology </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Gastroenterology/Alcoholic%20Hepatitis/ class=md-nav__link> Alcoholic Hepatitis </a> </li> <li class=md-nav__item> <a href=../../Gastroenterology/Ascending%20Cholangitis/ class=md-nav__link> Ascending Cholangitis </a> </li> <li class=md-nav__item> <a href=../../Gastroenterology/Bilirubin%20Physiology/ class=md-nav__link> Bilirubin Physiology </a> </li> <li class=md-nav__item> <a href=../../Gastroenterology/Portal%20Hypertension/ class=md-nav__link> Portal Hypertension </a> </li> <li class=md-nav__item> <a href=../../Gastroenterology/Spontaneous%20Bacterial%20Peritonitis/ class=md-nav__link> Spontaneous Bacterial Peritonitis </a> </li> <li class=md-nav__item> <a href=../../Gastroenterology/Variceal%20Bleeding%20in%20Cirrhosis/ class=md-nav__link> Variceal Bleeding </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_7 type=checkbox id=__nav_7> <label class=md-nav__link for=__nav_7> General Concepts <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="General Concepts" data-md-level=1> <label class=md-nav__title for=__nav_7> <span class="md-nav__icon md-icon"></span> General Concepts </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../General%20Concepts/Corticosteroid%20Comparison/ class=md-nav__link> Corticosteroid Comparison </a> </li> <li class=md-nav__item> <a href=../../General%20Concepts/Electrolyte%20Replacement%20Guide/ class=md-nav__link> Electrolyte Replacement Guide </a> </li> <li class=md-nav__item> <a href=../../General%20Concepts/Inpatient%20Glycemic%20Control/ class=md-nav__link> Inpatient Glycemic Control </a> </li> <li class=md-nav__item> <a href=../../General%20Concepts/Intravenous%20Fluids/ class=md-nav__link> Intravenous Fluids </a> </li> <li class=md-nav__item> <a href=../../General%20Concepts/Opioid%20Analgesia/ class=md-nav__link> Opioid Analgesia </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_8 type=checkbox id=__nav_8> <label class=md-nav__link for=__nav_8> Hematology <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Hematology data-md-level=1> <label class=md-nav__title for=__nav_8> <span class="md-nav__icon md-icon"></span> Hematology </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Hematology/ID%20in%20HF/ class=md-nav__link> Iron Deficiency in HF </a> </li> <li class=md-nav__item> <a href=../../Hematology/Iron%20Study%20Thresholds/ class=md-nav__link> Iron Deficiency - Iron Study Thresholds </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_9 type=checkbox id=__nav_9> <label class=md-nav__link for=__nav_9> Infectious Diseases <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label="Infectious Diseases" data-md-level=1> <label class=md-nav__title for=__nav_9> <span class="md-nav__icon md-icon"></span> Infectious Diseases </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Infectious%20Diseases/Antibiotics%20101/ class=md-nav__link> Antibiotics 101 </a> </li> <li class=md-nav__item> <a href=../../Infectious%20Diseases/Candidiasis/ class=md-nav__link> Candidiasis </a> </li> <li class=md-nav__item> <a href=../../Infectious%20Diseases/Clostridium%20difficile/ class=md-nav__link> Clostridium difficile Infection (CDI) </a> </li> <li class=md-nav__item> <a href=../../Infectious%20Diseases/Infective%20Endocarditis/ class=md-nav__link> Infective Endocarditis </a> </li> <li class=md-nav__item> <a href=../../Infectious%20Diseases/Legionella%20Infection/ class=md-nav__link> Legionella Infection </a> </li> <li class=md-nav__item> <a href=../../Infectious%20Diseases/Skin%20and%20Soft%20Tissue%20Infections/ class=md-nav__link> Skin and Soft Tissue Infections </a> </li> <li class=md-nav__item> <a href=../../Infectious%20Diseases/Tick%20Borne%20Infections/ class=md-nav__link> Tick Borne Infections </a> </li> <li class=md-nav__item> <a href=../../Infectious%20Diseases/Urinary%20Tract%20Infections/ class=md-nav__link> Urinary Tract Infections </a> </li> <li class=md-nav__item> <a href=../../Infectious%20Diseases/echocardiograms-in-bloodstream-infections/ class=md-nav__link> Echocardiograms in Bloodstream Infections </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_10 type=checkbox id=__nav_10> <label class=md-nav__link for=__nav_10> Neurology <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Neurology data-md-level=1> <label class=md-nav__title for=__nav_10> <span class="md-nav__icon md-icon"></span> Neurology </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Neurology/Acute%20Stroke/ class=md-nav__link> Acute Stroke </a> </li> <li class=md-nav__item> <a href=../../Neurology/Decerebrate%20versus%20Decorticate/ class=md-nav__link> Decerebrate versus Decorticate </a> </li> <li class=md-nav__item> <a href=../../Neurology/Delirium/ class=md-nav__link> Delirium </a> </li> <li class=md-nav__item> <a href=../../Neurology/Guillain-Barr%C3%A9%20Syndrome/ class=md-nav__link> Guillain-Barré Syndrome (GBS) </a> </li> <li class=md-nav__item> <a href=../../Neurology/Pronouncing%20Death/ class=md-nav__link> Pronouncing Death </a> </li> <li class=md-nav__item> <a href=../../Neurology/Status%20Epilepticus/ class=md-nav__link> Status Epilepticus </a> </li> </ul> </nav> </li> <li class="md-nav__item md-nav__item--nested"> <input class="md-nav__toggle md-toggle" data-md-toggle=__nav_11 type=checkbox id=__nav_11> <label class=md-nav__link for=__nav_11> Palliative <span class="md-nav__icon md-icon"></span> </label> <nav class=md-nav aria-label=Palliative data-md-level=1> <label class=md-nav__title for=__nav_11> <span class="md-nav__icon md-icon"></span> Palliative </label> <ul class=md-nav__list data-md-scrollfix> <li class=md-nav__item> <a href=../../Palliative/End%20of%20Life%20Orders/ class=md-nav__link> Pain or Dyspnea </a> </li> </ul> </nav> </li> </ul> </nav> </div> </div> </div> <div class="md-sidebar md-sidebar--secondary" data-md-component=sidebar data-md-type=toc> <div class=md-sidebar__scrollwrap> <div class=md-sidebar__inner> <nav class="md-nav md-nav--secondary" aria-label="Table of contents"> <label class=md-nav__title for=__toc> <span class="md-nav__icon md-icon"></span> Table of contents </label> <ul class=md-nav__list data-md-component=toc data-md-scrollfix> <li class=md-nav__item> <a href=#definitions-background class=md-nav__link> Definitions &amp; Background </a> </li> <li class=md-nav__item> <a href=#pathophysiology class=md-nav__link> Pathophysiology </a> </li> <li class=md-nav__item> <a href=#consequences class=md-nav__link> Consequences </a> </li> <li class=md-nav__item> <a href=#chronic-management-of-atrial-fibrillation class=md-nav__link> Chronic Management of Atrial Fibrillation </a> <nav class=md-nav aria-label="Chronic Management of Atrial Fibrillation"> <ul class=md-nav__list> <li class=md-nav__item> <a href=#rate-versus-rhythm-control class=md-nav__link> Rate versus Rhythm Control </a> </li> <li class=md-nav__item> <a href=#rate-control class=md-nav__link> Rate Control </a> </li> <li class=md-nav__item> <a href=#rhythm-control class=md-nav__link> Rhythm Control </a> </li> <li class=md-nav__item> <a href=#risk-stratification class=md-nav__link> Risk Stratification </a> <nav class=md-nav aria-label="Risk Stratification"> <ul class=md-nav__list> <li class=md-nav__item> <a href=#risk-of-stroke class=md-nav__link> Risk of Stroke </a> </li> <li class=md-nav__item> <a href=#risk-of-bleeding class=md-nav__link> Risk of Bleeding </a> </li> </ul> </nav> </li> <li class=md-nav__item> <a href=#anticoagulation class=md-nav__link> Anticoagulation </a> </li> </ul> </nav> </li> <li class=md-nav__item> <a href=#resources-references class=md-nav__link> Resources &amp; References </a> </li> </ul> </nav> </div> </div> </div> <div class=md-content data-md-component=content> <article class="md-content__inner md-typeset"> <h1 id=atrial-fibrillation>Atrial Fibrillation</h1> <h2 id=definitions-background><strong>Definitions &amp; Background</strong></h2> <p><strong>Atrial fibrillation (AF)</strong> is disorganized, rapid, irregular atrial activation with resulting loss of normal atrial contractions, and irregular ventricular rate. Untreated, the ventricular rate tends to be rapid and variable in the range of 120-160 bpm. AF is the most common sustained arrhythmia.</p> <p><strong>Risk factors</strong> can be divided into modifiable and non-modifiable risk factors:</p> <table> <thead> <tr> <th style=text-align:left>Modifiable</th> <th style=text-align:left>Non-Modifiable</th> </tr> </thead> <tbody> <tr> <td style=text-align:left> <ul> <li>hypertension</li> <li>obesity</li> <li>obstructive sleep apnea</li> <li>diabetes mellitus</li> <li>chronic kidney disease</li> <li>heavy alcohol use</li> </ul> </td> <td style=text-align:left> <ul> <li>age (&gt;95% of patients are 60 or older)</li> <li>male sex</li> <li>underlying cardiac disease</li> <li>Caucasian race</li> </ul> </td> </tr> </tbody> </table> <p><strong>Triggers</strong> of atrial fibrillation are varied:</p> <table> <thead> <tr> <th align=left>Category</th> <th align=left>Causes</th> </tr> </thead> <tbody> <tr> <td align=left>Cardiovascular</td> <td align=left>ischemic heart disease, valvular heart disease, hypertension, pericardial disease, cardiomyopathy, pulmonary embolism</td> </tr> <tr> <td align=left>Conduction</td> <td align=left>pre-excitation syndromes</td> </tr> <tr> <td align=left>Metabolic</td> <td align=left>thyrotoxicosis, electrolyte abnormalities (hypoK, hypoMg), acid-base abnormalities</td> </tr> <tr> <td align=left>Systemic</td> <td align=left>acute infection, surgery</td> </tr> <tr> <td align=left>Ingestion</td> <td align=left>acute alcohol consumption, sympathomimetics, digoxin, theophylline, adenosine</td> </tr> </tbody> </table> <p>Caffeine is not associated with atrial fibrillation.</p> <p><strong>EKG findings</strong> are an irregularly irregular rhythm, no P waves, no isoelectric baseline, variable ventricular rate, narrow QRS (usually), and possibly fine/coarse high-frequency fibrillatory waves (which may mimic P waves). The ventricular rate is often 110 to 160 bpm, and if it is above 100 then it is AF <strong>with rapid ventricular response</strong> a.k.a. &ldquo;AFRVR&rdquo;.</p> <p><img alt="af example.png" src=../img/af%20example.png></p> <h2 id=pathophysiology>Pathophysiology</h2> <p><img alt="types of af.png" src=../img/types%20of%20af.png></p> <p>Classically, AF can be a progressive condition that involves cardiac myocyte remodeling, fibrosis, and conduction abnormalities. Atrial dilatation, commonly seen in longstanding systemic hypertension, predisposes to ectopic atrial automaticity and abnormal electrical activity.</p> <p>Atrial fibrillation promotes atrial fibrillation.</p> <table> <thead> <tr> <th align=left>Classification</th> <th align=left>Definition</th> <th align=left>Process</th> </tr> </thead> <tbody> <tr> <td align=left><strong>Subclinical AF (SCAF)</strong></td> <td align=left>&ldquo;Asymptomatic episodes of AF detected by intracardiac, implantable, or wearable monitors and confirmed by intracardiac electrogram or review of the recorded rhythm on the electrocardiogram.&rdquo;</td> <td align=left>Unknown. Associated with progression to clinical AF, and with a risk of stroke.</td> </tr> <tr> <td align=left><strong>Paroxysmal AF</strong></td> <td align=left>Self-limiting, resolves within 7 days</td> <td align=left>Re-entry mechanism involving atrial muscle extending into the pulmonary veins (PVs).</td> </tr> <tr> <td align=left><strong>Persistent AF</strong></td> <td align=left>Lasts more than 7 days, or does not spontaneously resolve.</td> <td align=left>May involve the PVs, SVC, or the coronary sinus. Gradual fibrosis.</td> </tr> <tr> <td align=left><strong>Long-standing AF</strong></td> <td align=left>Uninterrupted for more than 1 year</td> <td align=left>Chronic atrial fibrosis, and difficult to restore and maintain normal sinus rhythm.</td> </tr> <tr> <td align=left><strong>Permanent AF</strong></td> <td align=left>Cannot return to normal sinus rhythm (NSR)</td> <td align=left>Irreversible electrophysiological remodeling.</td> </tr> </tbody> </table> <h2 id=consequences>Consequences</h2> <p>Loss of proper atrial contributions to ventricular filling promotes <strong>atrial hemostasis with predisposition to left atrial appendage (LAA) thrombus formation</strong>. Thromboembolic cerebrovascular disease results.</p> <p>Rapid ventricular rates can cause <strong>hemodynamic collapse</strong>, or <strong>heart failure exacerbations</strong>. This is particularly true with hypertrophic cardiomyopathy or heart failure with preserved ejection fraction (HFpEF). Over time, uncontrolled AF can lead to <strong>tachycardia-related cardiomyopathy.</strong></p> <p>Otherwise, symptoms related to inconsistent cardiac output might include fatigability, exercise intolerance, dizziness, and syncope.</p> <p>Why do we care if someone has AF? Because over time, it significantly increases the risk of serious and potentially irreversible conditions:</p> <ul> <li>mortality (by 1.5-1.9x)</li> <li>heart failure</li> <li>stroke (by 5x, causes 25% of strokes)</li> <li>dementia and vascular dementia</li> </ul> <h2 id=chronic-management-of-atrial-fibrillation>Chronic Management of Atrial Fibrillation</h2> <p>In general, patients who maintain sinus rhythm have better survival than those who continue to have AF. Therapy focuses on controlling the ventricular response to disordered atrial contractions, and reducing the risk of thromboembolic disease.</p> <h3 id=rate-versus-rhythm-control>Rate versus Rhythm Control</h3> <p>In 2002, the <a href=https://www.nejm.org/doi/full/10.1056/NEJMoa021328>AFFIRM trial (NEJM 2002)</a> compared <strong>rate control strategies</strong> (beta blockers, non-DHP CCBs, digoxin; target HR &lt;80 at rest and &lt;110 during 6-min walk test) to <strong>rhythm control strategies</strong> (amiodarone, disopyramide, flecainide, moricizine, procainamide, propafenone, quinidine, sotalol, dofetilide, and cardioversion) in <strong>patients 65 or older with chronic non-valvular AF, and eligible for anticoagulation with warfarin (target INR 2-3).</strong> Patients with rhythm control were encouraged to be on anticoagulation but were allowed to not be anticoagulated if NSR had been sustained for at least 4 (ideally 12) consecutive weeks. Patients with rate control had to be on constant anticoagulation. Overall, there was no survival differences between rate and rhythm approaches, but rhythm control trended towards increased mortality, especially in the elderly and those with no history of heart failure. There were fewer adverse drug effects with rate control.</p> <div class="admonition hint"> <p class=admonition-title>Hint</p> <ol> <li>Consider <strong>rhythm control</strong> if young and asymptomatic with no structural heart disease.</li> <li>Consider <strong>rate control</strong> if older with structural heart disease or a dilated left atrium.</li> </ol> </div> <h3 id=rate-control>Rate Control</h3> <p><strong>Goal:</strong> HR less than 100 at rest, according to the CCS Guidelines. However, the <a href=https://www.nejm.org/doi/full/10.1056/NEJMoa1001337>RACE II trial (NEJM 2010)</a> demonstrated that, over three years with a broad CV composite outcome, a lenient rate target (resting HR &lt;110 bpm) was noninferior to a strict rate control target (resting HR &lt; 80 bpm and &lt;110 bpm during moderate exercise). Not only that, but a lenient target increased the target success rate, decreased visits necessary to reach the target, decreased the number of patients on medications at all, and decreased the dosages of beta blockers, verapamil, and combination therapy.</p> <div class="admonition fyi"> <p>The <strong>RACE II (2010)</strong> trial supports a lenient heart rate approach (&lt;110 bpm at rest) in active patients with mild to moderate symptoms.</p> </div> <p>Common agents include: <strong>beta blockers</strong> (metoprolol, bisoprolol, etc), <strong>non-DHP CCBs</strong> (diltiazem, verapamil), <strong>digoxin</strong> (lacks negative inotropic effects, may be useful in heart failure).</p> <p><img alt="rate control.png" src=../img/rate%20control.png></p> <ol> <li><strong>Beta blockers</strong> are first-line therapy regardless of history of myocardial infarction or LV dysfunction.</li> <li><strong>Non-DHP CCBs</strong> are first-line as well with no history of MI or LV dysfunction. They are less preferred than BBs in the setting of CAD. Avoid in heart failure.</li> <li><strong>Digoxin</strong> is an option in those with LV systolic dysfunction, or if very sedentary. It is also used as add-on or second-line therapy to BBs and non-DHP CCBs.</li> <li><strong>Amiodarone</strong> is used in exceptional cases.</li> <li><strong>Dronedarone</strong> should not be used in permanent AF, or for the sole purpose of rate control. As well, do not use with history of heart failure or LVEF &lt; 40%. Be cautious if also using digoxin.</li> </ol> <p><strong>AV node ablation</strong> or a <strong>permanent pacemaker</strong> may be needed if maximum pharmacologic therapy fails to control rate.</p> <h3 id=rhythm-control>Rhythm Control</h3> <h3 id=risk-stratification>Risk Stratification</h3> <p>Most patients will warrant chronic anticoagulation. It is particularly indicated for those with <strong>mitral stenosis</strong>, <strong>HCM</strong>, and <strong>prior stroke</strong>. Otherwise, we tend to use clinical decision rules and risk stratification scores to make these decisions.</p> <h4 id=risk-of-stroke>Risk of Stroke</h4> <p>The <strong>CHA(2)DS(2)-VASc</strong> score has been used to estimate stroke risk in nonvalvular AF, and to make recommendations about chronic anticoagulation. Whether the AF is paroxysmal or persistent or not doesn&rsquo;t seem to make a large difference in terms of stroke risk. Long-term anticoagulation is indicated for women with score of 2 or more, and for men with a score of 3 or more.</p> <p _=% endhint=endhint>{% hint style=&rdquo;info&rdquo; %} <strong>Valvular AF</strong> is generally accepted to refer to atrial fibrillation with rheumatic heart disease (mainly mitral stenosis) and artificial heart valves.</p> <p><img alt=chadsvasc.png src=../img/chadsvasc.png></p> <table> <thead> <tr> <th align=left>CHA(2)DS(2)-VASc Score</th> <th align=left>Estimated Annual Stroke Rate (%)</th> </tr> </thead> <tbody> <tr> <td align=left>0</td> <td align=left>0</td> </tr> <tr> <td align=left>1</td> <td align=left>1.3</td> </tr> <tr> <td align=left>2</td> <td align=left>2.2</td> </tr> <tr> <td align=left>3</td> <td align=left>3.2</td> </tr> <tr> <td align=left>4</td> <td align=left>4.0</td> </tr> <tr> <td align=left>5</td> <td align=left>6.7</td> </tr> <tr> <td align=left>6-9</td> <td align=left>&gt;9</td> </tr> </tbody> </table> <p _=% endhint=endhint>{% hint style=&rdquo;info&rdquo; %} The annual risk of stroke starts at 0, and increases by approximately 1% for each point (until 4, after which it increases dramatically).</p> <p>In Canada, the recent <strong>CHADS65</strong> algorithm has supplanted previous scores in determining if patients should be on chronic anticoagulation. This has greatly simplified decision making. Of course, therapy must always be guided by patient preferences and individual circumstances.</p> <p><img alt=chads65.png src=../img/chads65.png></p> <h4 id=risk-of-bleeding>Risk of Bleeding</h4> <p>Any anticoagulant therapy increases the risk of bleeding; that is the nature of the mechanism. The <strong>HAS-BLED</strong> score estimates the risk of major bleeds. A score of 3 or more is considered high risk, and indicates close monitoring and followup.</p> <p><img alt=hasbled.png src=../img/hasbled.png></p> <h3 id=anticoagulation>Anticoagulation</h3> <p><strong>Warfarin</strong> has long been the standard anticoagulant for atrial fibrillation, and it remains the therapy of choice for those with mitral stenosis and mechanical heart valves. It is an epoxide reductase inhibitor that interferes with the activation of vitamin K in the body, mostly in the liver. It is particularly cheap, but requires monthly INR checks and has many drug-drug interactions. Onset of action is over several (3-5) days as enzyme inhibition does not have immediate effects of coagulation factors. Immediate reversal consists of prothrombin complex concentrate (PCC/Octaplex; coag factors 2, 7, 9, 10 and proteins C and S), fresh frozen plasma, and vitamin K. Vitamin K-dependent proteins are: <strong>coagulation factors 2, 7, 9, 10; proteins C and S</strong></p> <p><strong>Direct oral anticoagulants (DOACs)</strong> are newer inhibitors of coagulation factors that are more expensive and more convenient. DOACs are noninferior to warfarin in individual head-to-head trials for stroke prevention in atrial fibrillation, and may actually be superior by a small margin for reduction of mortality, stroke, major bleeds, and intracranial hemorrhage. No DOACs have been directly compared so far. In severe renal disease, consider warfarin. Otherwise, adjust dosages with tools such as <a href=https://thrombosiscanada.ca/tools/ >Thrombosis Canada&rsquo;s Dosing Tool</a>. Often, elderly patients are often inappropriately underdosed, meaning that they do not receive the proven benefits of anticoagulation, while receiving some of the bleeding risk.</p> <table> <thead> <tr> <th style=text-align:left>DOAC</th> <th style=text-align:left>Inhibited Factor</th> <th style=text-align:left>Dosing Considerations</th> <th style=text-align:left>Reversal Agent</th> </tr> </thead> <tbody> <tr> <td style=text-align:left>Dabigatran (Pradaxa)</td> <td style=text-align:left>IIa</td> <td style=text-align:left> <p>Avoid in ESRD</p> <p>BID</p> </td> <td style=text-align:left>idarucizumab (Praxbind)</td> </tr> <tr> <td style=text-align:left>Apixaban (Eliquis)</td> <td style=text-align:left>Xa</td> <td style=text-align:left> <p>Avoid in ESRD</p> <p>BID</p> </td> <td style=text-align:left>andexanet alfa (Andexxa)</td> </tr> <tr> <td style=text-align:left>Rivaroxaban (Xarelto)</td> <td style=text-align:left>Xa</td> <td style=text-align:left> <p>Avoid in ESRD</p> <p>once daily</p> </td> <td style=text-align:left>andexanet alfa (Andexxa)</td> </tr> <tr> <td style=text-align:left>Edoxaban (Lixiana)</td> <td style=text-align:left>Xa</td> <td style=text-align:left>once daily</td> <td style=text-align:left>andexanet alfa (Andexxa)</td> </tr> </tbody> </table> <h2 id=resources-references>Resources &amp; References</h2> <ol> <li><a href=http://www.ccs.ca/eguidelines/Content/Topics/AtrialFib/_landing_page_atrial_fibrillation.htm>Macle, Laurent et al. 2016 Focused Update of the CCS Guidelines for the Management of Atrial Fibrillation. Can J Cardiol 2016;32:1170-1185</a></li> <li><a href=https://www.nejm.org/doi/full/10.1056/NEJMoa021328>Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002 Dec 5;347(23):1825–33. </a></li> <li><a href=https://www.nejm.org/doi/full/10.1056/NEJMoa1001337>Van Gelder IC, Groenveld HF, Crijns HJGM, Tuininga YS, Tijssen JGP, Alings AM, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010 Apr 15;362(15):1363–73. </a></li> </ol> <hr> <div class=md-source-file> <small> Last update: <span class="git-revision-date-localized-plugin git-revision-date-localized-plugin-date">May 8, 2022</span> </small> </div> </article> </div> </div> </main> </div> <div class=md-dialog data-md-component=dialog> <div class="md-dialog__inner md-typeset"></div> </div> <script id=__config type=application/json>{"base": "../..", "features": [], "search": "../../assets/javascripts/workers/search.2a1c317c.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.config.lang": "en", "search.config.pipeline": "trimmer, stopWordFilter", "search.config.separator": "[\\s\\-]+", "search.placeholder": "Search", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version.title": "Select version"}}</script> <script src=../../assets/javascripts/bundle.ed9748b7.min.js></script> </body> </html>